Literature DB >> 6529531

Pseudoephedrine and triprolidine in plasma and breast milk of nursing mothers.

J W Findlay, R F Butz, J M Sailstad, J T Warren, R M Welch.   

Abstract

Plasma and milk concentrations of pseudoephedrine and triprolidine were determined (by radioimmunoassay) in three lactating mothers over 12-48 h after ingestion of a combination medication containing 60 mg of pseudoephedrine hydrochloride and 2.5 mg of triprolidine hydrochloride monohydrate. Pseudoephedrine concentrations in milk were consistently higher than those in plasma. The total amount of drug in milk, as judged by areas under the respective curves (AUC), was two to three times greater than in plasma. Triprolidine concentrations in milk and plasma were more variable between subjects than those of pseudoephedrine. AUC values for milk and plasma were similar for one subject, while the plasma value exceeded that for milk in another woman. The fraction of the dose excreted in milk was estimated to be 0.4-0.7% for pseudoephedrine and 0.06-0.2% for triprolidine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6529531      PMCID: PMC1463694          DOI: 10.1111/j.1365-2125.1984.tb02562.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Accumulation of atenolol and metoprolol in human breast milk.

Authors:  H Liedholm; A Melander; P O Bitzén; G Helm; G Lönnerholm; I Mattiasson; B Nilsson; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

2.  A comparison of plasma levels of L(+) pseudoephedrine following different formulations, and their relation to cardiovascular and subjective effects in man.

Authors:  C Bye; H M Hill; D T Hughes; A W Peck
Journal:  Eur J Clin Pharmacol       Date:  1975       Impact factor: 2.953

Review 3.  Excretion of drugs in human breast milk.

Authors:  R M Welch; J W Findlay
Journal:  Drug Metab Rev       Date:  1981       Impact factor: 4.518

4.  Stereospecific radioimmunoassays for d-pseudoephedrine in human plasma and their application to bioequivalency studies.

Authors:  J W Findlay; J T Warren; J A Hill; R M Welch
Journal:  J Pharm Sci       Date:  1981-06       Impact factor: 3.534

5.  Clindamycin passage into human milk.

Authors:  B Stéen; A Rane
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

Review 6.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

7.  Renal excretion of pseudoephedrine.

Authors:  D C Brater; S Kaojarern; L Z Benet; E T Lin; T Lockwood; R C Morris; E J McSherry; K L Melmon
Journal:  Clin Pharmacol Ther       Date:  1980-11       Impact factor: 6.875

8.  Urinary excretion of chlorpheniramine and pseudoephedrine in humans.

Authors:  C M Lai; R G Stoll; Z M Look; A Yacobi
Journal:  J Pharm Sci       Date:  1979-10       Impact factor: 3.534

9.  Analgesic drugs in breast milk and plasma.

Authors:  J W Findlay; R L DeAngelis; M F Kearney; R M Welch; J M Findlay
Journal:  Clin Pharmacol Ther       Date:  1981-05       Impact factor: 6.875

10.  Transplacental passage and breast milk concentrations of hydralazine.

Authors:  H Liedholm; E Wåhlin-Boll; A Hanson; I Ingemarsson; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more
  7 in total

1.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

2.  Safety of antihistamines during pregnancy and lactation.

Authors:  Miranda So; Pina Bozzo; Miho Inoue; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2010-05       Impact factor: 3.275

Review 3.  Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).

Authors:  D M Paton; D R Webster
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

4.  Pseudoephedrine: effects on milk production in women and estimation of infant exposure via breastmilk.

Authors:  Khalidah Aljazaf; Thomas W Hale; Kenneth F Ilett; Peter E Hartmann; Leon R Mitoulas; Judith H Kristensen; L Peter Hackett
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

Review 5.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 6.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 7.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.